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Sdr Boulevard 20, DK-500, Odense C, DenmarkIn this issue, Svensjö et al. provide a topical review of
screening for abdominal aortic aneurysms (AAAs).1 Review
articles serve an important purpose in synthesizing knowl-
edge, and, when conducted using a systematic approach
including quality assessment, they qualify as the highest
level evidence. However this is not the case for a topical
review, which may instead have a role in highlighting
noteworthy or controversial issues that are evolving in areas
where research moves at a fast pace.
In the AAA screening context, issues of such a kind
include, for example, prevalence. Svensjö et al. conclude
that falling prevalence may eradicate the cost-effectiveness
of screening, but this has already been demonstrated to
have an inferior impact in Sweden, the UK and Denmark.
For the latter, it has been showed that halving the preva-
lence (from 3.3% to 1.6%) reduced the probability of
screening being cost-effective by only one percentage point
(from 92.0% to 91.0%).2 Other relevant aspects of a modern
epidemiology concern increased incidental detection rate,
use of endovascular repair, reduced risk of surgical repair,
increased general cardiovascular prevention, and improved
survival of aneurysm patients, among others.
Cost-effectiveness is the major question in many coun-
tries that have not implemented screening programmes.
AAA probably acts similarly across borders, whereas prev-
alence, healthcare protocols, costs, and culture probably
differ. Ideally, a health economic model should therefore be
established for every context, building on parameter esti-
mates that hold validity for that particular context in order
to appropriately support decision making. As a second best,
existing studies can be reviewed but this should then be
accompanied by a formal quality assessment in order to
identify the validity of parameters and assumptions madeDOI of original article: http://dx.doi.org/10.1016/j.ejvs.2014.08.029
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http://dx.doi.org/10.1016/j.ejvs.2014.09.007during modelling. The last time such an exercise was per-
formed, severe sources of bias were identiﬁed mainly
against screening.3
Issues of great importance to future research are
rescreening, screening of women, and the interaction be-
tween cardiovascular conditions and the resulting potential
for synergy and/or economies of scope that can be achieved
by providing combined screening for different conditions.
One example is the Viborg Vascular (VIVA) trial, which is
evaluating combined screening for AAA, peripheral arterial
disease, and hypertension,4 where the 5 year results are
expected within the next year. With recently published
multicentre results of rescreening, studies on the value of
repeat screening should be conducted. However, in relation
to women, epidemiology needs to be addressed before
credible models can be developed.REFERENCES
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